Zobrazeno 1 - 10
of 97
pro vyhledávání: '"K K, Laktionov"'
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 172-177 (2022)
Non-small cell lung cancer is a very heterogeneous group of diseases. When choosing an effective patient management strategy, an oncologist focuses on the stage of the disease, the morphological form of the tumor, as well as its molecular genetic mar
Externí odkaz:
https://doaj.org/article/3afa4470b51643a49ee504769c39177e
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 157-162 (2022)
HCC is considered refractory when it comes to progression during treatment with TKIs (sorafenib, lenvatinib). The combined immunotherapy of nivolumab with ipilimumab was studied in the one cohort of CheckMate-040 study, excluding immunotherapy-naive
Externí odkaz:
https://doaj.org/article/88111f1fbbb34a1290aaebf398e8292a
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 14-20 (2022)
Lung cancer is one of the most common malignant tumors with the highest mortality, with about 85% of cases of the disease being non-small cell lung cancer. To date, adjuvant chemotherapy based on platinum preparations remains the standard of treatmen
Externí odkaz:
https://doaj.org/article/d9480ee32534481e8bfbc13818ee51ec
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 1, Pp 115-121 (2022)
The purpose of the study: to conduct a systematic literature review on the effectiveness and feasibility of using information on the presence of KRAS gene mutations (in different codons), TP 53 (KP), ST K11/LKB1 (KL), and KEAP mutations and the assoc
Externí odkaz:
https://doaj.org/article/d70e95fee7884b2bb385696709255c81
Autor:
E. Yu. Antonova, E. A. Moroz, D. V. Podluzhny, N. E. Kudashkin, I. A. Dzhanyan, A. Yu. Volkov, K. K. Laktionov, V. V. Breder
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 94-100 (2021)
Introduction. Fibrolamellar hepatocellular carcinoma (FLC), which develops most often in the younger population. In FLC, variable histoarchitectonics are noted, possibly the presence of a sclerosing component, foci of necrosis and dystrophy of tumor
Externí odkaz:
https://doaj.org/article/0fb253b580fd402d89fd7f26341a7465
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 62-67 (2021)
Introduction. Lorlatinib is a third generation ALK tyrosine kinase inhibitor. Back in 2018, the drug underwent accelerated FDA approval and was recommended for the treatment of patients with ALK-positive non-small cell lung cancer after progression o
Externí odkaz:
https://doaj.org/article/1c654f8c443e4a73bbe68d91b0c46fe5
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 150-154 (2021)
The optimal hepatocellular cancer (HCC) therapy remains a challenge. Due to checkpoint inhibitors patients with intolerance to the targeted therapy and or those with the impaired liver function can get an appropriate drug therapy. This clinical obser
Externí odkaz:
https://doaj.org/article/7d3b533bad6847ca98344d2b18409f5a
Autor:
D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, M. S. Ardzinba, E. V. Reutova, O. I. Borisova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 18-24 (2021)
Introduction. Lung cancer remains the one of the most common and fatal cancers in the world. For a long time, chemotherapy was the only treatment option for metastatic lung cancer. Currently, immunotherapy became the one of the preferred options of t
Externí odkaz:
https://doaj.org/article/2147954dcc9547a6a6fbf739228a60c2
Autor:
M. O. Mandrina, V. V. Breder, M. V. Ivanov, A. A. Lebedeva, V. V. Gorbatsevich, K. K. Laktionov, P. V. Kononets
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 154-159 (2021)
Personalized therapy is starting to play an increasing role in modern approaches to the treatment of oncological diseases. The previously existing uniform standard for each malignant disease is expanded with new options and treatment possibilities, d
Externí odkaz:
https://doaj.org/article/57964881696b4a4fb74301f5336982f7
Autor:
E. S. Denisova, K. K. Laktionov, T. N. Borisova, Merab. S. Ardzinba, A. A. Fedorova, D. I. Yudin, S. S. Magamedova, Milada A. Ardzinba
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 188-193 (2020)
The abscopal effect was described more than 50 years ago and is a phenomenon in which radiation therapy promotes the regression of metastatic foci remote from the site of radiation. For decades, this effect has been described as a rare, unexplained p
Externí odkaz:
https://doaj.org/article/1c63e70f6a7d4b39a81faaa91607768d